{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"Death during treatment or disease progression characterized by worsening of cytopenias, increase in the percentage of the blasts, reduction of hemoglobin concentration by at least 2 g/dl or transfusion dependence in the absence of another explanation, such as acute infection, gastrointestinal bleeding, hemolysis.","groups":[{"id":"OG000","title":"Azacitidine and Darbopoietin and G-CSF"}],"populationDescription":"Because no patients completed therapy, no analysis was possible","reportingStatus":"POSTED","timeFrame":"Approximately 12 months","title":"Time to Progression to Acute Myeloid Leukemia (Blast ≥ 20%) or Death","type":"SECONDARY"}